Background: There is a wide practice variation of used methods and outcomes in IUI in fertility laboratories. Standardization of the IUI procedure is important for reducing inconsistency among laboratories in counseling infertile couples and in pregnancy results. The aim of the study was to evaluate the currently used laboratory procedures of IUI in Dutch fertility laboratories and their effect on IUI pregnancy results. Additionally, the methods for semen analysis (SA) were evaluated, as SA is related to IUI in terms of inseminated sperm number and IUI counseling. Material and Methods: This questionnaire survey study was sent to laboratories participating in the Dutch external quality control program for semen analysis (SKML) and consisted of 46 questions concerning laboratory management, methods for semen analysis and IUI, and clinical results. The results were analyzed using univariable and multivariable logistic regression models. Results: A total of 52 laboratories (out of 99) provided information on used methodologies for SA or laboratory procedures of IUI and the organization of the laboratory. A wide variability was confirmed in used methods for both SA and IUI. Evaluation of pregnancy results obtained during 3 years (2013)(2014)(2015) showed that specific used laboratory methods have a significant effect on the probability of becoming pregnant. Discussion and conclusion: Important to remark is that in this survey study cycle-specific data, including variables of the individual couples (age, stimulation protocol, etc), were not included and may have effects on the results. The reported results provide an overview of the current practice performance; however, the organization of fertility laboratories is changing rapidly. The use of standardized methods in IUI is important for optimizing the performance of care and improving pregnancy results. The knowledge on used procedures, however, is limited, and further research on factors involving SA and the IUI procedure is necessary.
INTRODUCTION
Intrauterine insemination (IUI) is a commonly used procedure, conducted in many fertility clinics around the world (Calhaz-Jorge et al., 2016; Dyer et al., 2016) . The results of the treatment are dependent on many factors, such as female and male age, female factors, semen quality, and treatment type (e.g., natural vs. stimulated cycle, type of ovulation induction, and timing of the insemination). The best indications for IUI are moderate male factor and unexplained infertility (Ombelet, 2013) , with especially tubal factor infertility as contra-indication. Moreover, mild ovarian stimulation generally leads to better results than natural cycle IUI, thereby having a higher risk for multiple pregnancies (Guzick et al., 1999; Thijssen et al., 2017) . With respect to the effect of semen factors on IUI, studies report contradictive conclusions. Many authors report a minimum required motile sperm count (TMC) for effective IUI; however, there is no consensus about the exact value of this minimum (Tomlinson et al., 2013) . Next, to this minimum TMC, a maximum is reported in two studies (Lemmens et al., 2016; Thijssen et al., 2017) . Also, the impact of sperm morphology for successful IUI is under discussion. Although some groups report a certain impact of sperm morphology on the results of IUI, in a recent review, it was concluded that it has a very poor clinical impact both in diagnostics and in prediction of pregnancy after ART (Gatimel et al., 2017b) . One possibility to explain the differences in outcome of these sperm counts is laid in the variation in practice of semen analysis (SA) by laboratories (Tomlinson et al., 2013; Gatimel et al., 2017b) .
A same type of laboratory practice variation might be the origin of different pregnancy results after IUI. Despite the fact that there is a recommendation for both SA and sperm preparation for IUI (WHO 2010) , a recent literature review showed that the recommended methods for sperm preparation are characterized by a low level of evidence, insufficient literature, and controversial results (Lemmens et al., 2017) . On the other hand, from this literature review, some tentative conclusions could be made for an optimal procedure.
An overview of guideline adherence by laboratories of the technical stage of IUI is missing in the literature. Based on the results of an earlier survey (not published), we expect many variation, despite the fact that many laboratories introduced the ISO 15189 medical laboratory standard and besides an improved version of the WHO manual (World Health Organization, 2010) . As in the clinical part of IUI, where optimal guideline adherence was reported to have important economical benefits (Haagen et al., 2013) , this interlaboratory variation is undesirable. On the other hand, coupling this variation in laboratory methods to IUI pregnancy rates may provide more evidence with respect to the optimum procedure as extracted from the literature (Lemmens et al., 2017) .
Therefore, the objective of this study was to survey the different laboratory IUI procedures, to associate these methods with IUI pregnancy results and to compare these outcomes with the conclusions of the literature review. As SA results are an important factor for IUI counseling (Ombelet et al., 2014; Lemmens et al., 2016; Thijssen et al., 2017) , we also investigated the methods used for SA. It is highlighted that the study is a laboratory survey and is not including individual patient data that can influence the pregnancy results of IUI. Moreover, the study was limited to the situation in Dutch fertility laboratories. As SA and IUI are performed on large scale in the Netherlands and the foreseen variation is high, a sanguine outcome can be expected, informative for other countries as well.
MATERIALS AND METHODS
About hundred Dutch fertility laboratories participating in the regular external quality control program for SA were invited for this questionnaire survey study. In the Netherlands, the Dutch Foundation for Quality Assessment in Medical Laboratories (SKML) is a non-profit organization that organizes the external quality control of most Dutch laboratories performing SA.
An invitation for the survey study was sent by e-mail to the laboratories, together with the weblink of the electronic questionnaire (SurveyMonkeyâ). One reminder was sent 2 weeks later. The responses were received in May and June 2016.
Questionnaire development
The questionnaire was developed based on previous survey studies (Helmerhorst et al., 1995; Ombelet et al., 1997; Souter et al., 1997; Keel et al., 2002; Riddell et al., 2005) , our literature study (Lemmens et al., 2017) , and input of an expert panel. The questionnaire consisted of 46 questions. Most questions were closed-ended, and open-ended questions were used when the respondents should present quantitative data.
The questionnaire was constructed in Dutch and was designed to obtain information on the used methodologies of SA and IUI. In part A, the type of laboratory, quality management system, and staff on the laboratory were questioned. Part B consisted of questions about the technical performance of SA (i.e., assessment of concentration, morphology, and motility assessment) and the laboratory procedures of IUI (e.g., advised ejaculatory abstinence, semen collection place, and temperature during centrifugation/storage). In part C, participants were requested to present their data on IUI ongoing pregnancy (fetal heartbeat after 12 weeks of gestation) results in the period 2013-2015.
Statistical analyses
The results are presented as counts and percentages. The probability to become pregnant was modeled with logistic regression models, using the reported pregnancy results of 2013-2015. The dependent variable was pregnancy outcome (yes/no). The independent variables were semen collection place (at home or both in the clinic or at home), semen preparation technique (density gradient centrifugation, washing, swim-up, or swim-down), washing medium (HEPES or bicarbonate), temperature during storage (room temperature, body temperature, or no storage), method of timing IUI (hCG administration, LH surge, ultrasound, or a combination of these), and bed rest after insemination (direct mobilization or bed rest). The selection of independent variables was based on our literature review study (Lemmens et al., 2017) . First, univariable logistic regression models were fitted. The statistically significant independent variables were included in a multivariable logistic regression analysis with forward selection based on the Wald test for selecting a set of variables predicting the probability to become pregnant (based on a = 0.05). The crude odds ratios (ORs) with 95% confidence intervals (CIs) based on the univariable logistic regression model were estimated. The ORs with 95% CIs and the p-values of this final multivariable model are presented. The statistical analyses were performed using SPSS IBM Statistics 20.0 for Windows (Chicago, IL, USA).
RESULTS
Ninety-nine laboratories were invited for this study. A total of 52 questionnaires were received on SurveyMonkeyâ (response rate of 52.5%). Of these respondents, 49 completed the SA part and 48 the IUI part of the questionnaire. Pregnancy results were reported by 35 (2014/2015) or 36 (2013) laboratories.
Organization of the participating clinics
Most of the respondents characterized their laboratory as a clinical chemistry laboratory (73.1%), others as specialized fertility/embryology (15.4%), clinical microbiology (5.8%), or clinical pathology (5.8%) laboratories. Of the clinical chemistry laboratories, two indicated that their fertility procedures were performed at a separated, specialized fertility setting. A total of 536 laboratory technicians were involved in performing SA and 549 in performing sperm processing for IUI. On average, the mean number of IUI treatments per technician is 40 a year. Of the total group of employees responsible for performing SA and/or semen processing for IUI, nine (1.6%) were qualified clinical embryologists, four (0.7%) possessed another (post-) master's degree, 395 (68.6%) possessed a higher professional education, 166 (28.8%)
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An interdisciplinary meeting with the department of gynecology was organized once a year in 23.1% of the laboratories, twice a year in 21.2%, three or four times a year in 9.6%, and more than four times a year in 20.9% of the laboratories. One-quarter of the participating laboratories indicated that such meeting did not take place at their clinic. Couples are treated following clinical IUI protocols with either a natural or stimulated cycle in most laboratories (93.8%). Couples in the remaining three clinics were offered only stimulated IUI cycles.
About 60% of the laboratories stated that they perform an internal quality control program, where most of these programs (74.2%) included a component specified to SA. All included laboratories were accredited according to the ISO 15189 or similar.
Semen analysis
A total of 49 laboratories responded to the subset of questions about SA methodologies, one reaction was incomplete. For SA, the World Health Organization, 2010 reference values were most frequently used (75.5% of the laboratories), followed by the WHO 1999 reference values (20.4%). One laboratory combined the reference values of the World Health Organization, 2010 and a Dutch directive (KLEM/NVKC 2011).
The reported methodologies for SA are summarized in Table 1 . Recommendations of the WHO guideline on SA procedures are followed by a limited number of laboratories: Sperm concentration is determined using the improved Neubauer hemocytometer in 55.1% of the laboratories. With respect to sperm motility, about 40% of the laboratories use the WHO 1999 criteria (i.e., rapidly progressive, slowly progressive, non-progressive, and immotile), which is recommended by the ESHRE Special Interest Group Andrology in their Basic Course on Semen Analysis (Barratt et al., 2011) . Moreover, participants of this course are instructed to assess sperm motility at body temperature. This is followed by 80% of the laboratories, in most cases using a microscope stage heater (92.3%). Sperm morphology assessment seems to be considered of limited interest, because only a small majority of the laboratories (n = 25) performed this test during routine SA. Only two laboratories assess sperm morphology using the Papanicolaou stain.
Laboratory procedures of IUI
Of the total group of respondents, 48 (92.3%) laboratories performed semen processing for IUI treatment. The majority of these performed semen processing on 6 days (41.7%) or 7 days (50.0%) a week, with no difference in clinical outcome. The used laboratory procedures of IUI are summarized in Table 2 . The majority of the laboratories (72.9%) offered the couples the opportunity to collect semen both in the clinic and at home. In these clinics, semen collection usually took place at home in 25 laboratories (71.4%), at the clinic in 25.7% and only one laboratory stated that collection took place in both options at a ) in 11.6% of the laboratories. The density gradients were used in a single layer (30.2%) or a double layer (69.8%).
All respondents centrifuged the semen samples at room temperature. HEPES-buffered wash media (zwitterion-buffered) were commonly used and, pending insemination, the samples were stored at room temperature in 62.5% of the laboratories. Most laboratories reported a combination of methods for timing the moment of IUI (i.e., hCG administration, LH surge, or ultrasound). The reported time intervals between ovulation induction and insemination ranged between 8 and 48 h (median 36 h). After insemination, patients were asked to have bed rest for 10 min in one-quarter of the clinics, 10-15 min in 5.6%, and 15 min in 55.6% of the clinics, where others reported less common durations (i.e., 5, 20, or 30 min). In 18.8% of the clinics, no bed rest was advised.
Pregnancy results
About 35 laboratories presented their data on the number of performed SA, IUI cycles, and the pregnancy rates in 2013-2015. Table 3 summarizes these data, together with the calculated pregnancy rates per cycle. Overall, a total of 42,071 SA were performed in these clinics in the period of 2013-2015. Moreover, a total of 3734 ongoing pregnancies were reported in 42,613 IUI cycles. Subsequently, the mean pregnancy rates per cycle were 9.4%, 9.6%, and 9.6%, respectively, in 2013, 2014, and 2015. Regarding the organization of the participating laboratories, specialized laboratories (i.e., fertility/embryology) performed on average more SAs (1171 vs. 346) and IUI treatments (763 vs. 286) than other laboratories (i.e., clinical chemistry, microbiology, and pathology), while pregnancy rates were comparable (9.4% in specialized laboratories vs. 9.5% in others). This might indicate that both types of laboratories use the same indications and/or have the same variation in methods for IUI. Pregnancy rates were significantly lower in clinics performing IUI 5 days a week, while these were comparable in clinics with either a 6 or 7 days service.
In Table 4 , the crude ORs from the univariable and the multivariable logistic regression models are presented. The probability to become pregnant was positively influenced by the use of a HEPES-buffered washing medium compared to bicarbonate buffer (p = 0.02) and by storage at room temperature compared to storage at body temperature (p = 0.00). Higher pregnancy rates were also obtained in clinics that give the possibility to collect semen at home or in the clinic than in clinics that advice semen collection at home only (OR = 0.71, 95% CI (0.59-0.87)). Washonly had a negative effect compared to density gradient centrifugation (OR = 0.77, 95% CI (0.64-0.94)). Furthermore, the method of timing IUI was an independent variable, with a lower probability in the group using hCG administration (OR = 0.80, 95% CI (0.73-0.87)). This model was based on data from 33,233 reported cycles in the participating laboratories; in the other cycles were one or more variables missing.
DISCUSSION WITH CONCLUSIONS
As expected, this questionnaire survey study shows a wide variability of used methods on fertility laboratories in the Netherlands, especially for SA methods. With respect to IUI, some of the laboratory variables have a significant impact on reported pregnancy rates.
One possible explanation for the variation in methods may be found in the fact that the presented data give us an overview of the situation in 2016. Some of the respondents replied that the used methods were recently changed or that changes are planned in the near future due to re-organizations. This will especially bias the impact of different laboratory procedures on IUI outcome (Table 4) , as the reported methods were not always used during the total study period 2013-2015. The number of laboratories performing SA in the Netherlands is changing, mainly as a result of fusions of laboratories. This may lead to different points of view within the fused group of professionals.
In general, the measured variation is both alarming and interesting. Alarming, because by absence of reference material, a recommended and fully validated method is all we have. Using other, non-validated methods adds to the uncertainty associated with the quality of analysis and makes it inappropriate for laboratories to use WHO reference values. So, the situation could theoretically lead to inadequate patient selection for the different treatments and so possibly to lower results of these treatments. We have to be careful in this, because from this survey it is not clear whether or not alternative methods are validated against the WHO recommendations. Moreover, it should be mentioned that SA not only contributes to predicting pregnancy rates, but is also valuable in a wider andrological perspective: A poor result from SA should be a starting point for further evaluation of the man's health, for example, by testicular ultrasound or endocrine examination. The interesting part of the variation is laid in the fact that all responding laboratories were accredited according to ISO 15189 (or CCKL, a national erstwhile standard similar to ISO) but that this is not a guarantee that they follow the WHO recommendations. A possible explanation may be that accrediting bodies do not refer to these recommendations as they are no official standard (World Health Organization, 2010; Bahadur et al., 2016b) . A way to overcome this problem may be to write an ISO standard for SA and/or by implementing a checklist on SA by major scientific journals (Bjorndahl, 2016) . On the other hand, these 'top-down' strategies might not work as there apparently is a kind of resistance to follow the present recommendations.
This resistance arose from previous versions of the WHO manual (WHO 1992 , 1999 ) that were judged as incomplete and their introduction did not result in the use of standardized materials and methods among fertility laboratories for SA (Helmerhorst et al., 1995; Ombelet et al., 1997; Souter et al., 1997; Keel et al., 2002; Riddell et al., 2005) and IUI (Keel et al., 2002; Penn et al., 2011) . The most recent WHO manual can also be discussed, especially with respect to agreeability of the procedures. It can be expected that there is more willingness to implement recommendations with a higher level of evidence and/or simplicity. A 710 Andrology, 2018, 6, 707-713 good example of this is the examination of sperm morphology. In the Netherlands, this test is out of interest because gynecologists mainly use the validated Hunault model as predictive tool for pregnancy (Hunault et al., 2004; van der Steeg et al., 2007) . In this model, sperm morphology is not included as a parameter of relevance, which may lead to less willingness to perform the test or to perform it accurately. The questionnaire results confirm this hypothesis: Only half of the laboratories perform sperm morphology assessment of which only two use the Papanicolaou stain, as described by the WHO. A similar result was found in France (Gatimel et al., 2017a) . The risk of not performing sperm morphology assessment is complex to speculate about, as on the one hand, one might miss specific severe abnormalities which lead to infertility (e.g., globozoospermia, 100% short motile tails, 100% severe ERC, and 100% stress-induced elongated sperm heads) and, on the other hand, a poor performance may lead to unsuitability of the algorithm used for patient selection. With respect to the first point, the dilemma is that the incidence of these specific abnormalities is very low and therefore it will be difficult to train and instruct standard laboratories on these items.
Next to agreeability, also interpretation of the WHO recommendations can be a source of variation. For example, the abstinence time for SA as advised by WHO (2-7 days) is used by many laboratories also for IUI ( Table 2) . The WHO does, however, not give recommendations on this aspect for IUI, and shorter intervals are probably more effective for this treatment (Levitas et al., 2005 (Levitas et al., , 2006 Bahadur et al., 2016a) . The same is true for semen collection at home. As the WHO manual states that analysis should begin within one hour after ejaculation, this may be interpreted that there is some freedom in the sampling step. Some accreditation programs might see this as a high risk for loss of process control.
Next to the laboratory aspects, IUI guideline adherence in clinical studies was reported as far from optimal with a large variability between different hospitals (Haagen et al., 2010) . Even the use of a professional-directed strategy and a multifaceted patient-and professional-oriented strategy did not improve the implementation of a set of clinical guideline recommendations (Mourad et al., 2011) . Like shortcomings in the performance of SA, this could lead to a less careful inclusion of patients, thereby decreasing the effectiveness of the treatment. So, with respect to IUI guidelines, implementation on the laboratory and clinic faces similar problems. Moreover, this questionnaire study reported a limited number of team meetings with both clinic and laboratory professionals. We think that these interdisciplinary meetings, where clinical results should be systematically reviewed, are an important condition for best practice and quality improvement. A guideline combining both laboratory and clinical procedures could be the solution to overcome these problems. A first effort was made by reviewing the essential steps for the laboratory stage of IUI, including the pre-and postlaboratory processes (Lemmens et al., 2017) , thereby overlapping parts of the clinical process. From our literature review (Lemmens et al., 2017) , two conclusions could be drawn. First, most of the laboratory steps were characterized by a low level of evidence and, second, if evidence is available, guidelines do not always recommend this best practice. Surprisingly, when comparing process variables from this questionnaire with the results of the literature review (Lemmens et al., 2017) , it was found that there was an accordance of ≥75% on variables with the highest level of evidence (level 1 evidence (NICE 2013)). On the other hand, however, the review study reported no superior method for the variables which had significant influences on the probability to become pregnant in this study. So, it seems that this simple questionnaire study can further argue the results from the literature. This is interesting; however, caution is needed when interpreting some of these results, as these were based on a small group of fertility laboratories. For example, patients treated in clinics performing their IUI procedures during 5 days a week had a statistically significant lower probability to become pregnant (OR = 0.77, 95% CI (0.67-0.89)) compared to clinics with a 7 days week schedule. The first group, however, consists of only three laboratories. Another important remark is that this study included clinic-specific data, while cycle-specific data, including variables of the individual couples (age, stimulation protocol, etc.) would be more accurate. It may seem, for instance, that semen collection at home was less successful than for clinics allowing both home and clinic collection. However, this association is not as per definition causal as patients were not allocated randomly to either situation. Furthermore, the predictive power (area under the ROC curve) of the final model was low (AUC = 0.54, 95% CI (0.53-0.55)).
Altogether, the different laboratory procedures for both SA and IUI need more supporting evidence related to 'best practice', resulting in convincing guidelines which should be combined with clinical guidelines. A first step to reach this goal can be found in the most recent validation of the Hunault model in which, next to sperm motility, also sperm morphology and volume are included (Bensdorp et al., 2017) . In fact, this is a recognition of previous studies in which all semen parameters were found to be relevant for predicting fertility (Guzick et al., 2001; Jedrzejczak et al., 2008; Barratt et al., 2017) and this could be a motivation for laboratories to follow the guidelines and to improve their procedures. Furthermore, to constantly improve the guidelines, additional research is essential. The next step to evaluate the influences of laboratory procedures on pregnancy results is the use of well-designed, multicenter controlled (retrospective or prospective) trials using couple-specific data. Thereafter, an effort can be made to optimize care by improving the implementation of best practice in the IUI laboratory.
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